{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:37:23Z","timestamp":1787647043066,"version":"build-2736575974"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T00:00:00Z","timestamp":1450224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Mossakowski Medical Research Centre PAS","award":["Theme No 8"],"award-info":[{"award-number":["Theme No 8"]}]},{"name":"Mossakowski Medical Research Centre PAS","award":["Theme No 1"],"award-info":[{"award-number":["Theme No 1"]}]},{"name":"Mossakowski Medical Research Centre PAS","award":["Theme No 1"],"award-info":[{"award-number":["Theme No 1"]}]},{"name":"Mossakowski Medical Research Centre PAS","award":["Theme No 8"],"award-info":[{"award-number":["Theme No 8"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11064-015-1776-x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T04:41:28Z","timestamp":1450240888000},"page":"243-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["The Lipoxygenases: Their Regulation and Implication in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Grzegorz A.","family":"Czapski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Czubowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna B.","family":"Strosznajder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Strosznajder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,16]]},"reference":[{"issue":"1","key":"1776_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9(1):119\u2013128. doi: 10.1016\/s1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"1776_CR2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fnagi.2010.00142","volume":"2","author":"MP Lichtenstein","year":"2010","unstructured":"Lichtenstein MP, Carriba P, Masgrau R, Pujol A, Galea E (2010) Staging anti-inflammatory therapy in Alzheimer\u2019s disease. Front Aging Neurosci 2:142. doi: 10.3389\/fnagi.2010.00142","journal-title":"Front Aging Neurosci"},{"issue":"5054","key":"1776_CR3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256(5054):184\u2013185","journal-title":"Science"},{"issue":"5580","key":"1776_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356. doi: 10.1126\/science.1072994","journal-title":"Science"},{"issue":"9","key":"1776_CR5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10(9):698\u2013712. doi: 10.1038\/nrd3505","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"1776_CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cell.2010.07.006","volume":"142","author":"MS Wolfe","year":"2010","unstructured":"Wolfe MS, Selkoe DJ (2010) Giving Alzheimer\u2019s the old one-two. Cell 142(2):194\u2013196. doi: 10.1016\/j.cell.2010.07.006","journal-title":"Cell"},{"issue":"Suppl 1","key":"1776_CR7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","volume":"120","author":"ME Larson","year":"2012","unstructured":"Larson ME, Lesne SE (2012) Soluble A\u03b2 oligomer production and toxicity. J Neurochem 120(Suppl 1):125\u2013139. doi: 10.1111\/j.1471-4159.2011.07478.x","journal-title":"J Neurochem"},{"issue":"12","key":"1776_CR8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","volume":"9","author":"E Giacobini","year":"2013","unstructured":"Giacobini E, Gold G (2013) Alzheimer disease therapy\u2014moving from amyloid-beta to tau. Nat Rev Neurol 9(12):677\u2013686. doi: 10.1038\/nrneurol.2013.223","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"1776_CR9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","volume":"60","author":"SA Small","year":"2008","unstructured":"Small SA, Duff K (2008) Linking A\u03b2 and tau in late-onset Alzheimer\u2019s disease: a dual pathway hypothesis. Neuron 60(4):534\u2013542. doi: 10.1016\/j.neuron.2008.11.007","journal-title":"Neuron"},{"issue":"4","key":"1776_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14(4):388\u2013405. doi: 10.1016\/s1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"6","key":"1776_CR11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16(6):358\u2013372. doi: 10.1038\/nrn3880","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"1776_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Golenbock DT, Latz E (2015) Innate immunity in Alzheimer\u2019s disease. Nat Immunol 16(3):229\u2013236. doi: 10.1038\/ni.3102","journal-title":"Nat Immunol"},{"issue":"12","key":"1776_CR13","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1096\/fj.04-3620rev","volume":"19","author":"KP Townsend","year":"2005","unstructured":"Townsend KP, Pratico D (2005) Novel therapeutic opportunities for Alzheimer\u2019s disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 19(12):1592\u20131601. doi: 10.1096\/fj.04-3620rev","journal-title":"FASEB J"},{"issue":"30","key":"1776_CR14","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/138161208786404173","volume":"14","author":"M Hirohata","year":"2008","unstructured":"Hirohata M, Ono K, Yamada M (2008) Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds. Curr Pharm Des 14(30):3280\u20133294","journal-title":"Curr Pharm Des"},{"key":"1776_CR15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-2094-8-90","volume":"8","author":"J Miklossy","year":"2011","unstructured":"Miklossy J (2011) Alzheimer\u2019s disease\u2014a neurospirochetosis. Analysis of the evidence following Koch\u2019s and Hill\u2019s criteria. J Neuroinflamm 8:90. doi: 10.1186\/1742-2094-8-90","journal-title":"J Neuroinflamm"},{"issue":"10","key":"1776_CR16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","volume":"73","author":"C Holmes","year":"2009","unstructured":"Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D, Perry VH (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology 73(10):768\u2013774. doi: 10.1212\/WNL.0b013e3181b6bb95","journal-title":"Neurology"},{"issue":"12","key":"1776_CR17","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/ph7121028","volume":"7","author":"Y Nakagawa","year":"2014","unstructured":"Nakagawa Y, Chiba K (2014) Role of microglial m1\/m2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel) 7(12):1028\u20131048. doi: 10.3390\/ph7121028","journal-title":"Pharmaceuticals (Basel)"},{"issue":"10","key":"1776_CR18","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.4049\/jimmunol.1100225","volume":"187","author":"E Titos","year":"2011","unstructured":"Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Moran-Salvador E, Martinez-Clemente M, Arroyo V, Claria J (2011) Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol 187(10):5408\u20135418. doi: 10.4049\/jimmunol.1100225","journal-title":"J Immunol"},{"issue":"3","key":"1776_CR19","first-page":"10","volume":"60","author":"P Dubey","year":"2014","unstructured":"Dubey P, Shrivastava R, Tripathi C, Jain NK, Tewari BN, Lone MU, Baghel KS, Kumar V, Misra S, Bhadauria S, Bhatt ML (2014) Cyclooxygenase-2 inhibition attenuates hypoxic cancer cells induced m2-polarization of macrophages. Cell Mol Biol (Noisy-Le-Grand) 60(3):10\u201315","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"issue":"5","key":"1776_CR20","doi-asserted-by":"crossref","first-page":"e63451","DOI":"10.1371\/journal.pone.0063451","volume":"8","author":"YR Na","year":"2013","unstructured":"Na YR, Yoon YN, Son DI, Seok SH (2013) Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model. PLoS One 8(5):e63451. doi: 10.1371\/journal.pone.0063451","journal-title":"PLoS One"},{"issue":"9","key":"1776_CR21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/carcin\/bgr128","volume":"32","author":"Y Nakanishi","year":"2011","unstructured":"Nakanishi Y, Nakatsuji M, Seno H, Ishizu S, Akitake-Kawano R, Kanda K, Ueo T, Komekado H, Kawada M, Minami M, Chiba T (2011) COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin\/+ mouse polyps. Carcinogenesis 32(9):1333\u20131339. doi: 10.1093\/carcin\/bgr128","journal-title":"Carcinogenesis"},{"key":"1776_CR22","first-page":"983640","volume":"2012","author":"H Crehan","year":"2012","unstructured":"Crehan H, Hardy J, Pocock J (2012) Microglia, Alzheimer\u2019s disease, and complement. Int J Alzheimers Dis 2012:983640. doi: 10.1155\/2012\/983640","journal-title":"Int J Alzheimers Dis"},{"issue":"49","key":"1776_CR23","doi-asserted-by":"crossref","first-page":"47373","DOI":"10.1074\/jbc.M208788200","volume":"277","author":"KJ Moore","year":"2002","unstructured":"Moore KJ, El Khoury J, Medeiros LA, Terada K, Geula C, Luster AD, Freeman MW (2002) A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J Biol Chem 277(49):47373\u201347379. doi: 10.1074\/jbc.M208788200","journal-title":"J Biol Chem"},{"issue":"1","key":"1776_CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2001.7732","volume":"171","author":"LF Lue","year":"2001","unstructured":"Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD (2001) Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer\u2019s disease: identification of a cellular activation mechanism. Exp Neurol 171(1):29\u201345. doi: 10.1006\/exnr.2001.7732","journal-title":"Exp Neurol"},{"issue":"2","key":"1776_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368(2):117\u2013127. doi: 10.1056\/NEJMoa1211851","journal-title":"N Engl J Med"},{"issue":"4","key":"1776_CR26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","volume":"109","author":"CL Hsieh","year":"2009","unstructured":"Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, Seaman WE (2009) A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 109(4):1144\u20131156. doi: 10.1111\/j.1471-4159.2009.06042.x","journal-title":"J Neurochem"},{"issue":"10","key":"1776_CR27","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/j.1460-9568.2004.03729.x","volume":"20","author":"G Sessa","year":"2004","unstructured":"Sessa G, Podini P, Mariani M, Meroni A, Spreafico R, Sinigaglia F, Colonna M, Panina P, Meldolesi J (2004) Distribution and signaling of TREM2\/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur J Neurosci 20(10):2617\u20132628. doi: 10.1111\/j.1460-9568.2004.03729.x","journal-title":"Eur J Neurosci"},{"issue":"13","key":"1776_CR28","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/glia.20710","volume":"56","author":"S Frank","year":"2008","unstructured":"Frank S, Burbach GJ, Bonin M, Walter M, Streit W, Bechmann I, Deller T (2008) TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice. Glia 56(13):1438\u20131447. doi: 10.1002\/glia.20710","journal-title":"Glia"},{"issue":"4","key":"1776_CR29","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","volume":"88","author":"KI Mosher","year":"2014","unstructured":"Mosher KI, Wyss-Coray T (2014) Microglial dysfunction in brain aging and Alzheimer\u2019s disease. Biochem Pharmacol 88(4):594\u2013604. doi: 10.1016\/j.bcp.2014.01.008","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"1776_CR30","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1172\/JCI77487","volume":"125","author":"JU Johansson","year":"2015","unstructured":"Johansson JU, Woodling NS, Wang Q, Panchal M, Liang X, Trueba-Saiz A, Brown HD, Mhatre SD, Loui T, Andreasson KI (2015) Prostaglandin signaling suppresses beneficial microglial function in Alzheimer\u2019s disease models. J Clin Invest 125(1):350\u2013364. doi: 10.1172\/jci77487","journal-title":"J Clin Invest"},{"issue":"21","key":"1776_CR31","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","volume":"345","author":"BA In t\u2019 Veld","year":"2001","unstructured":"In t\u2019 Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer\u2019s disease. N Engl J Med 345(21):1515\u20131521","journal-title":"N Engl J Med"},{"issue":"21","key":"1776_CR32","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","volume":"289","author":"PS Aisen","year":"2003","unstructured":"Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289(21):2819\u20132826. doi: 10.1001\/jama.289.21.2819","journal-title":"JAMA"},{"issue":"12","key":"1776_CR33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/JGP.0b013e31818cd3a4","volume":"16","author":"GW Small","year":"2008","unstructured":"Small GW, Siddarth P, Silverman DH, Ercoli LM, Miller KJ, Lavretsky H, Bookheimer SY, Huang SC, Barrio JR, Phelps ME (2008) Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study. Am J Geriatr Psychiatry 16(12):999\u20131009. doi: 10.1097\/JGP.0b013e31818cd3a4","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"1776_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000078501","volume":"23","author":"CA Szekely","year":"2004","unstructured":"Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN (2004) Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer\u2019s disease: a systematic review. Neuroepidemiology 23(4):159\u2013169. doi: 10.1159\/000078501","journal-title":"Neuroepidemiology"},{"issue":"10","key":"1776_CR35","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41(10):1088\u20131093. doi: 10.1038\/ng.440","journal-title":"Nat Genet"},{"issue":"2","key":"1776_CR36","doi-asserted-by":"crossref","first-page":"e1001308","DOI":"10.1371\/journal.pgen.1001308","volume":"7","author":"EM Wijsman","year":"2011","unstructured":"Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R, Lee JH, Bird TD, Bennett DA, Diaz-Arrastia R, Goate AM, Farlow M, Ghetti B, Sweet RA, Foroud TM, Mayeux R (2011) Genome-wide association of familial late-onset Alzheimer\u2019s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet 7(2):e1001308. doi: 10.1371\/journal.pgen.1001308","journal-title":"PLoS Genet"},{"issue":"5","key":"1776_CR37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","volume":"83","author":"L Bertram","year":"2008","unstructured":"Bertram L, Lange C, Mullin K et al (2008) Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE. Am J Hum Genet 83(5):623\u2013632. doi: 10.1016\/j.ajhg.2008.10.008","journal-title":"Am J Hum Genet"},{"issue":"18","key":"1776_CR38","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18):1832\u20131840. doi: 10.1001\/jama.2010.574","journal-title":"JAMA"},{"issue":"10","key":"1776_CR39","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41(10):1094\u20131099. doi: 10.1038\/ng.439","journal-title":"Nat Genet"},{"issue":"5","key":"1776_CR40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R et al (2011) Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 43(5):429\u2013435. doi: 10.1038\/ng.803","journal-title":"Nat Genet"},{"issue":"5","key":"1776_CR41","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW et al (2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 43(5):436\u2013441. doi: 10.1038\/ng.801","journal-title":"Nat Genet"},{"issue":"2","key":"1776_CR42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S et al (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368(2):107\u2013116. doi: 10.1056\/NEJMoa1211103","journal-title":"N Engl J Med"},{"key":"1776_CR43","author":"RE Tanzi","year":"2012","unstructured":"Tanzi RE (2012) The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. doi: 10.1101\/cshperspect.a006296","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"1776_CR44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6(4):193\u2013201. doi: 10.1038\/nrneurol.2010.17","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1776_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1990.tb08813.x","volume":"55","author":"T Shimizu","year":"1990","unstructured":"Shimizu T, Wolfe LS (1990) Arachidonic acid cascade and signal transduction. J Neurochem 55(1):1\u201315","journal-title":"J Neurochem"},{"issue":"1","key":"1776_CR46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7827(97)00002-7","volume":"36","author":"S Yamamoto","year":"1997","unstructured":"Yamamoto S, Suzuki H, Ueda N (1997) Arachidonate 12-lipoxygenases. Prog Lipid Res 36(1):23\u201341","journal-title":"Prog Lipid Res"},{"issue":"1","key":"1776_CR47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0014-5793(99)00396-8","volume":"449","author":"H Kuhn","year":"1999","unstructured":"Kuhn H, Thiele BJ (1999) The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett 449(1):7\u201311","journal-title":"FEBS Lett"},{"issue":"4","key":"1776_CR48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.plipres.2006.02.003","volume":"45","author":"H Kuhn","year":"2006","unstructured":"Kuhn H, O\u2019Donnell VB (2006) Inflammation and immune regulation by 12\/15-lipoxygenases. Prog Lipid Res 45(4):334\u2013356. doi: 10.1016\/j.plipres.2006.02.003","journal-title":"Prog Lipid Res"},{"issue":"2","key":"1776_CR49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plipres.2007.12.004","volume":"47","author":"G Schmitz","year":"2008","unstructured":"Schmitz G, Ecker J (2008) The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 47(2):147\u2013155. doi: 10.1016\/j.plipres.2007.12.004","journal-title":"Prog Lipid Res"},{"issue":"2\u20133","key":"1776_CR50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(97)85419-2","volume":"326","author":"E Amandi-Burgermeister","year":"1997","unstructured":"Amandi-Burgermeister E, Tibes U, Kaiser BM, Friebe WG, Scheuer WV (1997) Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2. Eur J Pharmacol 326(2\u20133):237\u2013250","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"1776_CR51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bcp.2014.05.022","volume":"90","author":"ND Quach","year":"2014","unstructured":"Quach ND, Arnold RD, Cummings BS (2014) Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease. Biochem Pharmacol 90(4):338\u2013348. doi: 10.1016\/j.bcp.2014.05.022","journal-title":"Biochem Pharmacol"},{"issue":"3\u20134","key":"1776_CR52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","volume":"73","author":"CN Serhan","year":"2005","unstructured":"Serhan CN (2005) Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 73(3\u20134):141\u2013162. doi: 10.1016\/j.plefa.2005.05.002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"14","key":"1776_CR53","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1111\/j.1742-4658.2007.05908.x","volume":"274","author":"S Nigam","year":"2007","unstructured":"Nigam S (2007) Hepoxilins: novel enzymatic pathways and clinical significance. FEBS J 274(14):3493. doi: 10.1111\/j.1742-4658.2007.05908.x","journal-title":"FEBS J"},{"issue":"8","key":"1776_CR54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.5483\/BMBRep.2008.41.8.555","volume":"41","author":"C Kim","year":"2008","unstructured":"Kim C, Kim JY, Kim JH (2008) Cytosolic phospholipase A(2), lipoxygenase metabolites, and reactive oxygen species. BMB Rep 41(8):555\u2013559","journal-title":"BMB Rep"},{"issue":"34","key":"1776_CR55","doi-asserted-by":"crossref","first-page":"23679","DOI":"10.1074\/jbc.274.34.23679","volume":"274","author":"AR Brash","year":"1999","unstructured":"Brash AR (1999) Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 274(34):23679\u201323682","journal-title":"J Biol Chem"},{"key":"1776_CR56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0083-6729(08)60924-3","volume":"54","author":"HN Sorensen","year":"1998","unstructured":"Sorensen HN, Treuter E, Gustafsson JA (1998) Regulation of peroxisome proliferator-activated receptors. Vitam Horm 54:121\u2013166","journal-title":"Vitam Horm"},{"issue":"2","key":"1776_CR57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/bbrc.1997.6790","volume":"235","author":"TD Foley","year":"1997","unstructured":"Foley TD (1997) 5-HPETE is a potent inhibitor of neuronal Na+, K(+)-ATPase activity. Biochem Biophys Res Commun 235(2):374\u2013376. doi: 10.1006\/bbrc.1997.6790","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1776_CR58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1523\/JNEUROSCI.22-01-00257.2002","volume":"22","author":"AJ Hampson","year":"2002","unstructured":"Hampson AJ, Grimaldi M (2002) 12-Hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: evidence for a G-protein-coupled HETE receptor. J Neurosci 22(1):257\u2013264","journal-title":"J Neurosci"},{"issue":"3","key":"1776_CR59","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.pharmthera.2006.05.009","volume":"112","author":"O Werz","year":"2006","unstructured":"Werz O, Steinhilber D (2006) Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol Ther 112(3):701\u2013718. doi: 10.1016\/j.pharmthera.2006.05.009","journal-title":"Pharmacol Ther"},{"issue":"7\u20138","key":"1776_CR60","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0223-5234(03)00115-6","volume":"38","author":"C Charlier","year":"2003","unstructured":"Charlier C, Michaux C (2003) Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem 38(7\u20138):645\u2013659","journal-title":"Eur J Med Chem"},{"issue":"3","key":"1776_CR61","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.prostaglandins.2007.01.005","volume":"83","author":"P Rubin","year":"2007","unstructured":"Rubin P, Mollison KW (2007) Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids. Prostaglandins Other Lipid Mediat 83(3):188\u2013197. doi: 10.1016\/j.prostaglandins.2007.01.005","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"1","key":"1776_CR62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1124\/pr.56.1.4","volume":"56","author":"C Brink","year":"2004","unstructured":"Brink C, Dahlen SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T (2004) International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor. Pharmacol Rev 56(1):149\u2013157. doi: 10.1124\/pr.56.1.4","journal-title":"Pharmacol Rev"},{"issue":"7","key":"1776_CR63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2007.06.002","volume":"32","author":"O Radmark","year":"2007","unstructured":"Radmark O, Werz O, Steinhilber D, Samuelsson B (2007) 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem Sci 32(7):332\u2013341. doi: 10.1016\/j.tibs.2007.06.002","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"1776_CR64","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.biopsych.2013.04.009","volume":"74","author":"PF Giannopoulos","year":"2013","unstructured":"Giannopoulos PF, Chu J, Joshi YB, Sperow M, Li JG, Kirby LG, Pratico D (2013) 5-lipoxygenase activating protein reduction ameliorates cognitive deficit, synaptic dysfunction, and neuropathology in a mouse model of Alzheimer\u2019s disease. Biol Psychiatry 74(5):348\u2013356. doi: 10.1016\/j.biopsych.2013.04.009","journal-title":"Biol Psychiatry"},{"issue":"4","key":"1776_CR65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/mp.2013.23","volume":"19","author":"PF Giannopoulos","year":"2014","unstructured":"Giannopoulos PF, Chu J, Joshi YB, Sperow M, Li JG, Kirby LG, Pratico D (2014) Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer\u2019s disease. Mol Psychiatry 19(4):511\u2013518. doi: 10.1038\/mp.2013.23","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1776_CR66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2010.02.173","volume":"396","author":"O Radmark","year":"2010","unstructured":"Radmark O, Samuelsson B (2010) Regulation of the activity of 5-lipoxygenase, a key enzyme in leukotriene biosynthesis. Biochem Biophys Res Commun 396(1):105\u2013110. doi: 10.1016\/j.bbrc.2010.02.173","journal-title":"Biochem Biophys Res Commun"},{"issue":"35","key":"1776_CR67","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1073\/pnas.0605150103","volume":"103","author":"M Rakonjac","year":"2006","unstructured":"Rakonjac M, Fischer L, Provost P, Werz O, Steinhilber D, Samuelsson B, Radmark O (2006) Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc Natl Acad Sci USA 103(35):13150\u201313155. doi: 10.1073\/pnas.0605150103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"1776_CR68","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1021\/bi980371g","volume":"37","author":"KI Skorey","year":"1998","unstructured":"Skorey KI, Gresser MJ (1998) Calcium is not required for 5-lipoxygenase activity at high phosphatidyl choline vesicle concentrations. Biochemistry 37(22):8027\u20138034. doi: 10.1021\/bi980371g","journal-title":"Biochemistry"},{"issue":"3","key":"1776_CR69","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood.V99.3.1044","volume":"99","author":"O Werz","year":"2002","unstructured":"Werz O, Burkert E, Samuelsson B, Radmark O, Steinhilber D (2002) Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes. Blood 99(3):1044\u20131052","journal-title":"Blood"},{"issue":"10","key":"1776_CR70","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1073\/pnas.050588997","volume":"97","author":"O Werz","year":"2000","unstructured":"Werz O, Klemm J, Samuelsson B, Radmark O (2000) 5-lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases. Proc Natl Acad Sci USA 97(10):5261\u20135266. doi: 10.1073\/pnas.050588997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"49","key":"1776_CR71","doi-asserted-by":"crossref","first-page":"40609","DOI":"10.1074\/jbc.M507045200","volume":"280","author":"M Luo","year":"2005","unstructured":"Luo M, Jones SM, Flamand N, Aronoff DM, Peters-Golden M, Brock TG (2005) Phosphorylation by protein kinase a inhibits nuclear import of 5-lipoxygenase. J Biol Chem 280(49):40609\u201340616. doi: 10.1074\/jbc.M507045200","journal-title":"J Biol Chem"},{"issue":"2","key":"1776_CR72","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/mol.62.2.250","volume":"62","author":"N Flamand","year":"2002","unstructured":"Flamand N, Surette ME, Picard S, Bourgoin S, Borgeat P (2002) Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol Pharmacol 62(2):250\u2013256","journal-title":"Mol Pharmacol"},{"issue":"40","key":"1776_CR73","doi-asserted-by":"crossref","first-page":"41512","DOI":"10.1074\/jbc.M312568200","volume":"279","author":"M Luo","year":"2004","unstructured":"Luo M, Jones SM, Phare SM, Coffey MJ, Peters-Golden M, Brock TG (2004) Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523. J Biol Chem 279(40):41512\u201341520. doi: 10.1074\/jbc.M312568200","journal-title":"J Biol Chem"},{"issue":"9","key":"1776_CR74","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1016\/S0021-9258(18)53251-8","volume":"268","author":"F Weitzel","year":"1993","unstructured":"Weitzel F, Wendel A (1993) Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone. J Biol Chem 268(9):6288\u20136292","journal-title":"J Biol Chem"},{"issue":"3","key":"1776_CR75","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bcp.2005.04.018","volume":"70","author":"O Werz","year":"2005","unstructured":"Werz O, Steinhilber D (2005) Development of 5-lipoxygenase inhibitors\u2014lessons from cellular enzyme regulation. Biochem Pharmacol 70(3):327\u2013333. doi: 10.1016\/j.bcp.2005.04.018","journal-title":"Biochem Pharmacol"},{"issue":"17","key":"1776_CR76","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1073\/pnas.0308523101","volume":"101","author":"AK Mandal","year":"2004","unstructured":"Mandal AK, Skoch J, Bacskai BJ, Hyman BT, Christmas P, Miller D, Yamin TT, Xu S, Wisniewski D, Evans JF, Soberman RJ (2004) The membrane organization of leukotriene synthesis. Proc Natl Acad Sci USA 101(17):6587\u20136592. doi: 10.1073\/pnas.0308523101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1776_CR77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/clpt.1994.96","volume":"56","author":"M Depre","year":"1994","unstructured":"Depre M, Friedman B, Van Hecken A, de Lepeleire I, Tanaka W, Dallob A, Shingo S, Porras A, Lin C, de Schepper PJ (1994) Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase-activating protein inhibitor. Clin Pharmacol Ther 56(1):22\u201330","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1776_CR78","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1096\/fasebj.12.6.439","volume":"12","author":"T Uz","year":"1998","unstructured":"Uz T, Pesold C, Longone P, Manev H (1998) Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. FASEB J 12(6):439\u2013449","journal-title":"FASEB J"},{"issue":"9","key":"1776_CR79","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.neurobiolaging.2006.06.007","volume":"28","author":"CM Chinnici","year":"2007","unstructured":"Chinnici CM, Yao Y, Pratico D (2007) The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old. Neurobiol Aging 28(9):1457\u20131462. doi: 10.1016\/j.neurobiolaging.2006.06.007","journal-title":"Neurobiol Aging"},{"key":"1776_CR80","doi-asserted-by":"crossref","first-page":"209596","DOI":"10.1155\/2009\/209596","volume":"2009","author":"S Dzitoyeva","year":"2009","unstructured":"Dzitoyeva S, Imbesi M, Ng LW, Manev H (2009) 5-Lipoxygenase DNA methylation and mRNA content in the brain and heart of young and old mice. Neural Plast 2009:209596. doi: 10.1155\/2009\/209596","journal-title":"Neural Plast"},{"issue":"1","key":"1776_CR81","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbalip.2009.09.003","volume":"1801","author":"C Katryniok","year":"2010","unstructured":"Katryniok C, Schnur N, Gillis A, von Knethen A, Sorg BL, Looijenga L, Radmark O, Steinhilber D (2010) Role of DNA methylation and methyl-DNA binding proteins in the repression of 5-lipoxygenase promoter activity. Biochim Biophys Acta 1801(1):49\u201357. doi: 10.1016\/j.bbalip.2009.09.003","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1776_CR82","first-page":"237","volume":"30","author":"H Chen","year":"2012","unstructured":"Chen H, Dzitoyeva S, Manev H (2012) Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus. Restor Neurol Neurosci 30(3):237\u2013245. doi: 10.3233\/rnn-2012-110223","journal-title":"Restor Neurol Neurosci"},{"issue":"5","key":"1776_CR83","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neurobiolaging.2013.11.016","volume":"35","author":"YB Joshi","year":"2014","unstructured":"Joshi YB, Giannopoulos PF, Chu J, Pratico D (2014) Modulation of lipopolysaccharide-induced memory insult, gamma-secretase, and neuroinflammation in triple transgenic mice by 5-lipoxygenase. Neurobiol Aging 35(5):1024\u20131031. doi: 10.1016\/j.neurobiolaging.2013.11.016","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1776_CR84","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1096\/fj.07-9131.com","volume":"22","author":"O Firuzi","year":"2008","unstructured":"Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Pratico D (2008) 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer\u2019s disease. FASEB J 22(4):1169\u20131178. doi: 10.1096\/fj.07-9131.com","journal-title":"FASEB J"},{"issue":"12","key":"1776_CR85","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1369\/jhc.2008.951855","volume":"56","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Abrahamson EE, Uz T, Manev H, Dekosky ST (2008) Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer\u2019s disease. J Histochem Cytochem 56(12):1065\u20131073. doi: 10.1369\/jhc.2008.951855","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"1776_CR86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-130506","volume":"37","author":"A Francesco Di","year":"2013","unstructured":"Di Francesco A, Arosio B, Gussago C, Dainese E, Mari D, D\u2019Addario C, Maccarrone M (2013) Involvement of 5-lipoxygenase in Alzheimer\u2019s disease: a role for DNA methylation. J Alzheimers Dis 37(1):3\u20138. doi: 10.3233\/jad-130506","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1776_CR87","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.22234","volume":"69","author":"J Chu","year":"2011","unstructured":"Chu J, Pratico D (2011) 5-lipoxygenase as an endogenous modulator of amyloid beta formation in vivo. Ann Neurol 69(1):34\u201346. doi: 10.1002\/ana.22234","journal-title":"Ann Neurol"},{"issue":"4","key":"1776_CR88","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.ajpath.2010.12.032","volume":"178","author":"J Chu","year":"2011","unstructured":"Chu J, Pratico D (2011) Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer\u2019s disease transgenic mouse model involvement of gamma-secretase. Am J Pathol 178(4):1762\u20131769. doi: 10.1016\/j.ajpath.2010.12.032","journal-title":"Am J Pathol"},{"issue":"3","key":"1776_CR89","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JAD-131223","volume":"38","author":"YB Joshi","year":"2014","unstructured":"Joshi YB, Di Meco A, Pratico D (2014) Modulation of amyloid-beta production by leukotriene B4 via the gamma-secretase pathway. J Alzheimers Dis 38(3):503\u2013506. doi: 10.3233\/jad-131223","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"1776_CR90","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.biopsych.2014.06.003","volume":"77","author":"J Chu","year":"2015","unstructured":"Chu J, Li JG, Joshi YB, Giannopoulos PF, Hoffman NE, Madesh M, Pratico D (2015) Gamma secretase-activating protein is a substrate for caspase-3: implications for Alzheimer\u2019s disease. Biol Psychiatry 77(8):720\u2013728. doi: 10.1016\/j.biopsych.2014.06.003","journal-title":"Biol Psychiatry"},{"key":"1776_CR91","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1038\/srep11086","volume":"5","author":"J Chu","year":"2015","unstructured":"Chu J, Li JG, Hoffman NE, Stough AM, Madesh M, Pratico D (2015) Regulation of gamma-secretase activating protein by the 5Lipoxygenase: in vitro and in vivo evidence. Sci Rep 5:11086. doi: 10.1038\/srep11086","journal-title":"Sci Rep"},{"issue":"11","key":"1776_CR92","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.neurobiolaging.2014.05.016","volume":"35","author":"A Meco Di","year":"2014","unstructured":"Di Meco A, Lauretti E, Vagnozzi AN, Pratico D (2014) Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer\u2019s disease mice. Neurobiol Aging 35(11):2458\u20132464. doi: 10.1016\/j.neurobiolaging.2014.05.016","journal-title":"Neurobiol Aging"},{"key":"1776_CR93","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-9-127","volume":"9","author":"J Chu","year":"2012","unstructured":"Chu J, Pratico D (2012) Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer\u2019s disease mouse model. J Neuroinflamm 9:127. doi: 10.1186\/1742-2094-9-127","journal-title":"J Neuroinflamm"},{"issue":"1","key":"1776_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-7-1","volume":"7","author":"J Chu","year":"2012","unstructured":"Chu J, Giannopoulos PF, Ceballos-Diaz C, Golde TE, Pratico D (2012) Adeno-associated virus-mediated brain delivery of 5-lipoxygenase modulates the AD-like phenotype of APP mice. Mol Neurodegener 7(1):1. doi: 10.1186\/1750-1326-7-1","journal-title":"Mol Neurodegener"},{"issue":"3","key":"1776_CR95","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ana.23642","volume":"72","author":"J Chu","year":"2012","unstructured":"Chu J, Giannopoulos PF, Ceballos-Diaz C, Golde TE, Pratico D (2012) 5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease. Ann Neurol 72(3):442\u2013454. doi: 10.1002\/ana.23642","journal-title":"Ann Neurol"},{"issue":"5","key":"1776_CR96","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biopsych.2012.12.012","volume":"74","author":"J Chu","year":"2013","unstructured":"Chu J, Li JG, Ceballos-Diaz C, Golde T, Pratico D (2013) The influence of 5-lipoxygenase on Alzheimer\u2019s disease-related tau pathology: in vivo and in vitro evidence. Biol Psychiatry 74(5):321\u2013328. doi: 10.1016\/j.biopsych.2012.12.012","journal-title":"Biol Psychiatry"},{"key":"1776_CR97","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1038\/tp.2013.106","volume":"3","author":"J Chu","year":"2013","unstructured":"Chu J, Lauretti E, Di Meco A, Pratico D (2013) FLAP pharmacological blockade modulates metabolism of endogenous tau in vivo. Transl Psychiatry 3:e333. doi: 10.1038\/tp.2013.106","journal-title":"Transl Psychiatry"},{"issue":"25","key":"1776_CR98","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.1523\/JNEUROSCI.5183-12.2013","volume":"33","author":"E Valera","year":"2013","unstructured":"Valera E, Dargusch R, Maher PA, Schubert D (2013) Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer\u2019s disease. J Neurosci 33(25):10512\u201310525. doi: 10.1523\/jneurosci.5183-12.2013","journal-title":"J Neurosci"},{"key":"1776_CR99","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainres.2010.07.096","volume":"1356","author":"GA Czapski","year":"2010","unstructured":"Czapski GA, Gajkowska B, Strosznajder JB (2010) Systemic administration of lipopolysaccharide induces molecular and morphological alterations in the hippocampus. Brain Res 1356:85\u201394. doi: 10.1016\/j.brainres.2010.07.096","journal-title":"Brain Res"},{"issue":"1","key":"1776_CR100","doi-asserted-by":"crossref","first-page":"e15163","DOI":"10.1371\/journal.pone.0015163","volume":"6","author":"S Puccio","year":"2011","unstructured":"Puccio S, Chu J, Pratico D (2011) Involvement of 5-lipoxygenase in the corticosteroid-dependent amyloid beta formation: in vitro and in vivo evidence. PLoS One 6(1):e15163. doi: 10.1371\/journal.pone.0015163","journal-title":"PLoS One"},{"issue":"4","key":"1776_CR101","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/acel.12096","volume":"12","author":"YB Joshi","year":"2013","unstructured":"Joshi YB, Chu J, Pratico D (2013) Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice. Aging Cell 12(4):706\u2013711. doi: 10.1111\/acel.12096","journal-title":"Aging Cell"},{"issue":"10","key":"1776_CR102","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1097\/00001756-200107200-00031","volume":"12","author":"A Lebeau","year":"2001","unstructured":"Lebeau A, Esclaire F, Rostene W, Pelaprat D (2001) Baicalein protects cortical neurons from beta-amyloid (25\u201335) induced toxicity. NeuroReport 12(10):2199\u20132202","journal-title":"NeuroReport"},{"issue":"8","key":"1776_CR103","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.cdd.4401395","volume":"11","author":"A Lebeau","year":"2004","unstructured":"Lebeau A, Terro F, Rostene W, Pelaprat D (2004) Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by beta-amyloid peptide. Cell Death Differ 11(8):875\u2013884. doi: 10.1038\/sj.cdd.4401395","journal-title":"Cell Death Differ"},{"issue":"1","key":"1776_CR104","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(94)91586-5","volume":"654","author":"Y Goodman","year":"1994","unstructured":"Goodman Y, Steiner MR, Steiner SM, Mattson MP (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res 654(1):171\u2013176","journal-title":"Brain Res"},{"issue":"8","key":"1776_CR105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuint.2005.06.012","volume":"47","author":"P Ferrera","year":"2005","unstructured":"Ferrera P, Arias C (2005) Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells. Neurochem Int 47(8):589\u2013596. doi: 10.1016\/j.neuint.2005.06.012","journal-title":"Neurochem Int"},{"issue":"5","key":"1776_CR106","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0002-9440(10)61224-2","volume":"167","author":"CM Chinnici","year":"2005","unstructured":"Chinnici CM, Yao Y, Ding T, Funk CD, Pratico D (2005) Absence of 12\/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient mice. Am J Pathol 167(5):1371\u20131377. doi: 10.1016\/s0002-9440(10)61224-2","journal-title":"Am J Pathol"},{"issue":"1\u20132","key":"1776_CR107","first-page":"65","volume":"8","author":"D Piomelli","year":"1994","unstructured":"Piomelli D (1994) Eicosanoids in synaptic transmission. Crit Rev Neurobiol 8(1\u20132):65\u201383","journal-title":"Crit Rev Neurobiol"},{"issue":"4","key":"1776_CR108","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ana.20558","volume":"58","author":"Y Yao","year":"2005","unstructured":"Yao Y, Clark CM, Trojanowski JQ, Lee VM, Pratico D (2005) Elevation of 12\/15 lipoxygenase products in AD and mild cognitive impairment. Ann Neurol 58(4):623\u2013626. doi: 10.1002\/ana.20558","journal-title":"Ann Neurol"},{"issue":"8","key":"1776_CR109","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.cdd.4400908","volume":"8","author":"M Maccarrone","year":"2001","unstructured":"Maccarrone M, Melino G, Finazzi-Agro A (2001) Lipoxygenases and their involvement in programmed cell death. Cell Death Differ 8(8):776\u2013784. doi: 10.1038\/sj.cdd.4400908","journal-title":"Cell Death Differ"},{"issue":"4","key":"1776_CR110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0306-3623(93)90153-O","volume":"24","author":"CR Pace-Asciak","year":"1993","unstructured":"Pace-Asciak CR (1993) Hepoxilins. Gen Pharmacol 24(4):805\u2013810","journal-title":"Gen Pharmacol"},{"issue":"1","key":"1776_CR111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/bj2660063","volume":"266","author":"S Dho","year":"1990","unstructured":"Dho S, Grinstein S, Corey EJ, Su WG, Pace-Asciak CR (1990) Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils. Biochem J 266(1):63\u201368","journal-title":"Biochem J"},{"issue":"8","key":"1776_CR112","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1073\/pnas.87.8.3037","volume":"87","author":"CR Pace-Asciak","year":"1990","unstructured":"Pace-Asciak CR, Laneuville O, Su WG, Corey EJ, Gurevich N, Wu P, Carlen PL (1990) A glutathione conjugate of hepoxilin A3: formation and action in the rat central nervous system. Proc Natl Acad Sci USA 87(8):3037\u20133041","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3\u20134","key":"1776_CR113","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.plefa.2007.08.007","volume":"77","author":"MP Zafiriou","year":"2007","unstructured":"Zafiriou MP, Deva R, Ciccoli R, Siafaka-Kapadai A, Nigam S (2007) Biological role of hepoxilins: upregulation of phospholipid hydroperoxide glutathione peroxidase as a cellular response to oxidative stress? Prostaglandins Leukot Essent Fatty Acids 77(3\u20134):209\u2013215. doi: 10.1016\/j.plefa.2007.08.007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"1776_CR114","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1471-4159.2009.06379.x","volume":"111","author":"S Pallast","year":"2009","unstructured":"Pallast S, Arai K, Wang X, Lo EH, van Leyen K (2009) 12\/15-Lipoxygenase targets neuronal mitochondria under oxidative stress. J Neurochem 111(3):882\u2013889. doi: 10.1111\/j.1471-4159.2009.06379.x","journal-title":"J Neurochem"},{"issue":"8","key":"1776_CR115","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1111\/j.1460-9568.2004.03650.x","volume":"20","author":"H Wang","year":"2004","unstructured":"Wang H, Li J, Follett PL, Zhang Y, Cotanche DA, Jensen FE, Volpe JJ, Rosenberg PA (2004) 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci 20(8):2049\u20132058. doi: 10.1111\/j.1460-9568.2004.03650.x","journal-title":"Eur J Neurosci"},{"issue":"47","key":"1776_CR116","doi-asserted-by":"crossref","first-page":"10616","DOI":"10.1523\/JNEUROSCI.2469-04.2004","volume":"24","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Wang H, Li J, Jimenez DA, Levitan ES, Aizenman E, Rosenberg PA (2004) Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation. J Neurosci 24(47):10616\u201310627. doi: 10.1523\/jneurosci.2469-04.2004","journal-title":"J Neurosci"},{"issue":"8","key":"1776_CR117","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0166-2236(00)01610-6","volume":"23","author":"JH Weiss","year":"2000","unstructured":"Weiss JH, Sensi SL (2000) Ca2+\u2013Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration. Trends Neurosci 23(8):365\u2013371","journal-title":"Trends Neurosci"},{"issue":"5","key":"1776_CR118","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1046\/j.1471-4159.2000.0751878.x","volume":"75","author":"E Aizenman","year":"2000","unstructured":"Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, Reynolds IJ (2000) Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 75(5):1878\u20131888","journal-title":"J Neurochem"},{"issue":"5","key":"1776_CR119","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)63724-8","volume":"164","author":"D Pratico","year":"2004","unstructured":"Pratico D, Zhukareva V, Yao Y, Uryu K, Funk CD, Lawson JA, Trojanowski JQ, Lee VM (2004) 12\/15-lipoxygenase is increased in Alzheimer\u2019s disease: possible involvement in brain oxidative stress. Am J Pathol 164(5):1655\u20131662. doi: 10.1016\/s0002-9440(10)63724-8","journal-title":"Am J Pathol"},{"issue":"1","key":"1776_CR120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1471-4159.2007.04742.x","volume":"103","author":"F Succol","year":"2007","unstructured":"Succol F, Pratico D (2007) A role for 12\/15 lipoxygenase in the amyloid beta precursor protein metabolism. J Neurochem 103(1):380\u2013387. doi: 10.1111\/j.1471-4159.2007.04742.x","journal-title":"J Neurochem"},{"issue":"1","key":"1776_CR121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ana.22625","volume":"71","author":"J Chu","year":"2012","unstructured":"Chu J, Zhuo JM, Pratico D (2012) Transcriptional regulation of beta-secretase-1 by 12\/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments. Ann Neurol 71(1):57\u201367. doi: 10.1002\/ana.22625","journal-title":"Ann Neurol"},{"issue":"10","key":"1776_CR122","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.biopsych.2010.04.010","volume":"68","author":"H Yang","year":"2010","unstructured":"Yang H, Zhuo JM, Chu J, Chinnici C, Pratico D (2010) Amelioration of the Alzheimer\u2019s disease phenotype by absence of 12\/15-lipoxygenase. Biol Psychiatry 68(10):922\u2013929. doi: 10.1016\/j.biopsych.2010.04.010","journal-title":"Biol Psychiatry"},{"issue":"11","key":"1776_CR123","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/mp.2014.170","volume":"20","author":"J Chu","year":"2015","unstructured":"Chu J, Li JG, Giannopoulos PF, Blass BE, Childers W, Abou-Gharbia M, Pratico D (2015) Pharmacologic blockade of 12\/15-lipoxygenase ameliorates memory deficits, A\u03b2 and tau neuropathology in the triple-transgenic mice. Mol Psychiatry 20(11):1329\u20131338. doi: 10.1038\/mp.2014.170","journal-title":"Mol Psychiatry"},{"issue":"6","key":"1776_CR124","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/acel.12136","volume":"12","author":"PF Giannopoulos","year":"2013","unstructured":"Giannopoulos PF, Joshi YB, Chu J, Pratico D (2013) The 12-15-lipoxygenase is a modulator of Alzheimer\u2019s-related tau pathology in vivo. Aging Cell 12(6):1082\u20131090. doi: 10.1111\/acel.12136","journal-title":"Aging Cell"},{"issue":"5","key":"1776_CR125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11064-011-0412-7","volume":"36","author":"JB Strosznajder","year":"2011","unstructured":"Strosznajder JB, Cieslik M, Cakala M, Jesko H, Eckert A, Strosznajder RP (2011) Lipoxygenases and poly(ADP-ribose) polymerase in amyloid beta cytotoxicity. Neurochem Res 36(5):839\u2013848. doi: 10.1007\/s11064-011-0412-7","journal-title":"Neurochem Res"},{"issue":"2","key":"1776_CR126","doi-asserted-by":"crossref","first-page":"339","DOI":"10.18388\/abp.2008_3081","volume":"55","author":"M Pytlowany","year":"2008","unstructured":"Pytlowany M, Strosznajder JB, Jesko H, Cakala M, Strosznajder RP (2008) Molecular mechanism of PC12 cell death evoked by sodium nitroprusside, a nitric oxide donor. Acta Biochim Pol 55(2):339\u2013347","journal-title":"Acta Biochim Pol"},{"issue":"4","key":"1776_CR127","first-page":"283","volume":"48","author":"K Czubowicz","year":"2010","unstructured":"Czubowicz K, Czapski GA, Cieslik M, Strosznajder RP (2010) Lipoxygenase inhibitors protect brain cortex macromolecules against oxidation evoked by nitrosative stress. Folia Neuropathol 48(4):283\u2013292","journal-title":"Folia Neuropathol"},{"issue":"5","key":"1776_CR128","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S1734-1140(12)70914-3","volume":"64","author":"GA Czapski","year":"2012","unstructured":"Czapski GA, Czubowicz K, Strosznajder RP (2012) Evaluation of the antioxidative properties of lipoxygenase inhibitors. Pharmacol Rep 64(5):1179\u20131188","journal-title":"Pharmacol Rep"},{"issue":"10","key":"1776_CR129","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","volume":"115","author":"WJ Lukiw","year":"2005","unstructured":"Lukiw WJ, Cui JG, Marcheselli VL, Bodker M, Botkjaer A, Gotlinger K, Serhan CN, Bazan NG (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115(10):2774\u20132783. doi: 10.1172\/jci25420","journal-title":"J Clin Invest"},{"issue":"Suppl","key":"1776_CR130","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1194\/jlr.R800068-JLR200","volume":"50","author":"NG Bazan","year":"2009","unstructured":"Bazan NG (2009) Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer\u2019s disease. J Lipid Res 50(Suppl):S400\u2013S405. doi: 10.1194\/jlr.R800068-JLR200","journal-title":"J Lipid Res"},{"issue":"5","key":"1776_CR131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1474-4422(02)00133-3","volume":"1","author":"PS Aisen","year":"2002","unstructured":"Aisen PS (2002) The potential of anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease. Lancet Neurol 1(5):279\u2013284","journal-title":"Lancet Neurol"},{"issue":"2","key":"1776_CR132","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.expneurol.2011.11.022","volume":"235","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ (2012) NF-kB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp Neurol 235(2):484\u2013490. doi: 10.1016\/j.expneurol.2011.11.022","journal-title":"Exp Neurol"},{"issue":"Pt 6","key":"1776_CR133","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1042\/BST0341277","volume":"34","author":"WJ Lukiw","year":"2006","unstructured":"Lukiw WJ, Bazan NG (2006) Survival signalling in Alzheimer\u2019s disease. Biochem Soc Trans 34(Pt 6):1277\u20131282. doi: 10.1042\/bst0341277","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"1776_CR134","doi-asserted-by":"crossref","first-page":"e15816","DOI":"10.1371\/journal.pone.0015816","volume":"6","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, Lukiw WJ, Bazan NG (2011) Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer\u2019s disease models. PLoS One 6(1):e15816. doi: 10.1371\/journal.pone.0015816","journal-title":"PLoS One"},{"issue":"9","key":"1776_CR135","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2967\/jnumed.107.049619","volume":"49","author":"G Esposito","year":"2008","unstructured":"Esposito G, Giovacchini G, Liow JS, Bhattacharjee AK, Greenstein D, Schapiro M, Hallett M, Herscovitch P, Eckelman WC, Carson RE, Rapoport SI (2008) Imaging neuroinflammation in Alzheimer\u2019s disease with radiolabeled arachidonic acid and PET. J Nucl Med 49(9):1414\u20131421. doi: 10.2967\/jnumed.107.049619","journal-title":"J Nucl Med"},{"key":"1776_CR136","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1038\/tp.2011.27","volume":"1","author":"JS Rao","year":"2011","unstructured":"Rao JS, Rapoport SI, Kim HW (2011) Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer\u2019s disease brain. Transl Psychiatry 1:e31. doi: 10.1038\/tp.2011.27","journal-title":"Transl Psychiatry"},{"issue":"5","key":"1776_CR137","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuint.2013.01.020","volume":"62","author":"GA Czapski","year":"2013","unstructured":"Czapski GA, Adamczyk A, Strosznajder RP, Strosznajder JB (2013) Expression and activity of PARP family members in the hippocampus during systemic inflammation: their role in the regulation of prooxidative genes. Neurochem Int 62(5):664\u2013673. doi: 10.1016\/j.neuint.2013.01.020","journal-title":"Neurochem Int"},{"issue":"1","key":"1776_CR138","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1194\/jlr.M200298-JLR200","volume":"44","author":"TA Rosenberger","year":"2003","unstructured":"Rosenberger TA, Villacreses NE, Contreras MA, Bonventre JV, Rapoport SI (2003) Brain lipid metabolism in the cPLA2 knockout mouse. J Lipid Res 44(1):109\u2013117","journal-title":"J Lipid Res"},{"issue":"6057","key":"1776_CR139","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","volume":"334","author":"DK Nomura","year":"2011","unstructured":"Nomura DK, Morrison BE, Blankman JL, Long JZ, Kinsey SG, Marcondes MC, Ward AM, Hahn YK, Lichtman AH, Conti B, Cravatt BF (2011) Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334(6057):809\u2013813. doi: 10.1126\/science.1209200","journal-title":"Science"},{"issue":"5","key":"1776_CR140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","volume":"28","author":"PL McGeer","year":"2007","unstructured":"McGeer PL, McGeer EG (2007) NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28(5):639\u2013647. doi: 10.1016\/j.neurobiolaging.2006.03.013","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1776_CR141","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JC Breitner","year":"2011","unstructured":"Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN (2011) Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 7(4):402\u2013411. doi: 10.1016\/j.jalz.2010.12.014","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"issue":"2","key":"1776_CR142","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12325-011-0100-7","volume":"29","author":"BP Burnett","year":"2012","unstructured":"Burnett BP, Levy RM (2012) 5-Lipoxygenase metabolic contributions to NSAID-induced organ toxicity. Adv Ther 29(2):79\u201398. doi: 10.1007\/s12325-011-0100-7","journal-title":"Adv Ther"},{"issue":"7","key":"1776_CR143","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1358\/mf.2005.27.7.920929","volume":"27","author":"M Bishnoi","year":"2005","unstructured":"Bishnoi M, Patil CS, Kumar A, Kulkarni SK (2005) Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice. Methods Find Exp Clin Pharmacol 27(7):465\u2013470. doi: 10.1358\/mf.2005.27.7.920929","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"278","key":"1776_CR144","doi-asserted-by":"crossref","first-page":"278ra233","DOI":"10.1126\/scitranslmed.aaa2512","volume":"7","author":"G Leinenga","year":"2015","unstructured":"Leinenga G, Gotz J (2015) Scanning ultrasound removes amyloid-beta and restores memory in an Alzheimer\u2019s disease mouse model. Sci Transl Med 7(278):278ra233. doi: 10.1126\/scitranslmed.aaa2512","journal-title":"Sci Transl Med"},{"key":"1776_CR145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuroscience.2014.09.061","volume":"302","author":"CH Latta","year":"2015","unstructured":"Latta CH, Brothers HM, Wilcock DM (2015) Neuroinflammation in Alzheimer\u2019s disease; a source of heterogeneity and target for personalized therapy. Neuroscience 302:103\u2013111. doi: 10.1016\/j.neuroscience.2014.09.061","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"1776_CR146","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1038\/sj.bjp.0707489","volume":"153","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153(Suppl 1):S200\u2013S215. doi: 10.1038\/sj.bjp.0707489","journal-title":"Br J Pharmacol"},{"issue":"2\u20133","key":"1776_CR147","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.plefa.2009.05.024","volume":"81","author":"NG Bazan","year":"2009","unstructured":"Bazan NG (2009) Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids 81(2\u20133):205\u2013211. doi: 10.1016\/j.plefa.2009.05.024","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-015-1776-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-015-1776-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T03:13:07Z","timestamp":1718248387000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-015-1776-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,16]]},"references-count":147,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1776"],"URL":"https:\/\/doi.org\/10.1007\/s11064-015-1776-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,16]]}}}